Ferguson James J. III 4
4 · Matinas BioPharma Holdings, Inc. · Filed Feb 27, 2019
Insider Transaction Report
Form 4
Ferguson James J. III
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2019-02-25+350,000→ 350,000 totalExercise: $1.09Exp: 2029-02-24→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests as to 25% of the shares on February 25, 2020 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on March 31, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.